SCHEMBL7992174

SCHEMBL7992174

O=c1[nH]c(-c2ccccn2)nc2ncn(Cc3cccc(Cl)c3)c12

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 7/20 0.48
ALDH1A1 P00352 5/20 0.48
KMT2A Q03164 2/20 0.47
HPGD P15428 1/20 0.46
HTT P42858 3/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
GLA P06280 1/20 0.45
UBE2N P61088 1/20 0.45
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
CBFB Q13951 1/20 0.41
MAPK1 P28482 2/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 1/20 0.40
HIF1A Q16665 1/20 0.40
HTR6 P50406 1/20 0.40
AGTR1 P30556 2/20 0.39
OPRK1 P41145 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7985490 0.90 ALDH1A1 (0.56) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7974003 0.88 ALDH1A1 (0.45) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7991785 0.88 HPGD (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7988662 0.86 SMN1; SMN2 (0.53) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7985453 0.85 GAA (0.52) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7973624 0.85 SMN1; SMN2 (0.48) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL8056885 0.84 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7974051 0.84 ALDH1A1 (0.47) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7991530 0.84 HPGD (0.48) SMN1; SMN2ALDH1A1KMT2AHPGDHTT
SCHEMBL7992180 0.84 SMN1; SMN2 (0.45) SMN1; SMN2KMT2AHTTL3MBTL1GLA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6310070-B1 FOR TREATING NEPHRITIS, IMPROVING PROTEINURIA DUE TO GLOMERULONEPHRITIS AND PREVENTING AGGRAVATION OF NEPHRITIS JAPAN ENERGY CORPORATION (JP) 2001-10-30 US disclosed
EP-0999211-A1 NOVEL PURINE DERIVATIVES AND MEDICINAL USE THEREOF JAPAN ENERGY CORPORATION (JP) 2000-05-10 EP disclosed